People with public health insurance will likely be able to make their health data from the electronic patient record (ePA) available for research starting in November 2026. To ensure this is done in compliance with data protection regulations, software tools are needed that anonymize sensitive…
The Berlin Institute of Health at Charité (BIH) today launched a groundbreaking analytical platform that combines high-resolution 3D light microscopy, molecular genomic and proteomic analysis, and AI-driven evaluation. Developed in partnership with Roche Diagnostics, RoX Health, ZEISS, Bruker…
Genome sequencing has revolutionized the diagnosis of rare diseases. For many patients, however, it is not sufficient on its own to reach a definitive diagnosis. In these cases, combining genomic data with protein values in the patients’ blood can provide more insight into rare diseases. This was…
CAR T-cell therapies are used successfully to treat certain blood cancers. However, while some patients respond even to low-dose treatment, others derive no benefit. Researchers from the Heidelberg Faculty of Medicine at Heidelberg University and the Berlin Institute of Health at Charité (BIH)…
An EU-funded research project coordinated by the Berlin Institute of Health at Charité (BIH) has uncovered how the pancreas develops, adapts, and changes in disease. The study has now been published in Cell Metabolism.
Researchers led by BIH Professor Enrico Klotzsch, from the Advanced and Personalized Therapies division, have discovered a previously unknown method for activating B cells through contact with a specific surface structure.
With Professor Jonathan Kimmelman, the Berlin Institute of Health at Charité (BIH) is gaining one of the world’s leading experts in Bioethics. His planned appointment to a Humboldt Professorship for Ethics, Policy, and Meta-Research at the BIH QUEST Center for Responsible Research will further…
Different types of bone marrow stem cells give rise to blood and immune cells. A team led by Simon Haas now reports in “Nature Cell Biology” how that diversity develops. The findings could help improve stem cell therapies, including treatments for blood cancers.
Whether it’s new treatment options for cancer, rare diseases, or age-related conditions - leading researchers and experts from clinical practice and industry are gathering in Frankfurt am Main to share their knowledge on modern gene and cell therapies.
Involving a collaboration with 118 investigators contributing from 89 institutions, scientists from the and Berlin Institute of Health at Charité (BIH) and the Precision Healthcare University Research Institute (Queen Mary University of London) have led the world’s largest study on the genetic…
A simple tool, developed by Researchers from Queen Mary University of London and the Berlin Institute of Health at Charité, could help identify which people living with obesity or overweight are most likely to develop serious obesity-related conditions such as type 2 diabetes and heart disease.
In aggressive lymphomas, inflammatory messengers reprogram the “conductors” of the immune system, causing lymph nodes structure to collapse. A team led by Simon Haas describes in “Nature Cancer” this process for the first time using single-cell and spatial analyses.